Pappas Ventures is our firm’s flagship business. For 29 years, we have invested in opportunities where we see the potential to generate superior risk-adjusted returns by focusing on novel life science products and technologies that have the potential to address significant unmet medical needs. We focus on opportunities where we have an advantage due to our specific expertise, insight or market reach.
From the very beginning we have invested across the United States and Canada, with a focus on underserved markets outside of California and the Northeast, such as Montreal and our home territory of Research Triangle Park, North Carolina, among other regions, that produce world class medical research but don’t get as much attention from venture investors as they deserve.
Venture funds raised
IPOs or M&A transactions across the Pappas portfolio
Companies sold for $1 billion or more
Companies founded or co-founded by Pappas
Investment opportunities evaluated each year
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.